Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy

This publication has 13 references indexed in Scilit:

• The Influence of Finasteride on the Development of Prostate Cancer
  New England Journal of Medicine, 2003
• TREATMENT CHANGES IN PROSTATIC HYPERPLASIA AND CANCER, INCLUDING ANDROGEN DEPRIVATION THERAPY AND RADIOTHERAPY
  Urologic Clinics of North America, 1999
• Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate Cancer
  Journal of Clinical Oncology, 1999
• Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?
  Urology, 1999
• A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
  JNCI Journal of the National Cancer Institute, 1998
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
  Published by American Medical Association (AMA) ,1997
• Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy
  Urology, 1997
• Effect of Neoadjuvant Endocrine Therapy (Combined Androgen Blockade) on Normal Prostate and Prostatic Carcinoma
  The American Journal of Surgical Pathology, 1996
• Effect of Combination Endocrine Therapy (LHRH Agonist and Flutamide) on Normal Prostate and Prostatic Adenocarcinoma
  The American Journal of Surgical Pathology, 1991
• Effect of castration, DES, flutamide, and the 5α-reductase inhibitor, MK-906, on the growth of the dunning rat prostatic carcinoma, R-3327
  The Prostate, 1991